Health ❯Healthcare

Diabetes

Type 2 Diabetes Type 1 Diabetes Medications Diabetes Management Insulin Treatment Diabetes Medications Treatment Treatment Options Weight Loss Management

Amgen Advances Monthly Obesity Drug to Phase 3 After 20% Weight Loss in Mid-Stage Trial

Amgen plans to use lower starting doses with gradual escalation to improve tolerability ahead of expanded Phase 3 studies

Semaglutide Demonstrates Dual Promise in Type 1 Diabetes and Dementia Prevention

Novo Nordisk’s Amycretin Achieves Up to 24% Weight Loss as It Advances to Phase 3

Eli Lilly’s Oral GLP-1 Pill Matches Injectables in Weight and Blood Sugar Control

Real-World GLP-1 Therapy Yields Lower Weight Loss, Spurs Tetra-Receptor Drug Research

GLP-1 Agonists Tied to Higher Risk of Macular Degeneration and Rare Optic Neuropathy

Mounjaro Delivers Rapid Weight Loss as UK Health Officials Warn of Serious Risks

Skin barrier test could reshape diabetic foot ulcer closure standards

FDA Chief Criticizes Medical Establishment, Advocates Lifestyle Changes for Health

First Human Trial of Type 1 Diabetes Immunotherapy Underway in Australia

Eli Lilly's Oral GLP-1 Pill Demonstrates Success in Phase 3 Trials

WeightWatchers Prepares for Bankruptcy as Weight Loss Drug Demand Surges

Eli Lilly's Mounjaro Launches in India, Targeting Obesity and Diabetes

Eli Lilly Launches Mounjaro in India to Address Obesity and Diabetes

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

Amgen Advances Weight-Loss Drug MariTide with Two Phase 3 Trials

Study Highlights Benefits and Risks of Popular Weight-Loss Drugs

Ozempic Linked to Rare Eye Condition, EU to Investigate

Weight-Loss Injections Linked to Increased Fertility and 'Ozempic Babies'

Diabetes and Obesity Drugs Found to Protect Kidney Health